Two people follow the same training program, eat similar diets, and put in comparable effort, yet one packs on visible muscle while the other progresses much more slowly. Training consistency, nutrition, sleep, and recovery all matter enormously, but genetics also shapes the raw materials your muscles have to work with, including a protein called alpha-actinin-3, encoded by the gene ACTN3. A common variant completely eliminates this protein from fast-twitch muscle fibers in people with two copies, and it has been repeatedly linked to differences in power, speed, and strength-training adaptations across many populations of athletes (Del Coso et al., 2022). Genetics is one contributing factor among several, not a ceiling that training can’t meaningfully push against.
ACTN3: The Gene Behind Fast-Twitch Fiber Function
Alpha-actinin-3 is a structural protein found specifically in fast-twitch (type II) muscle fibers, the fibers responsible for forceful, explosive contractions. A common nonsense mutation, R577X, prevents the protein from being made at all in people with two copies of the X variant.
Strong for Speed, Murkier for Strength
A study of nearly 1,000 Korean athletes found the protein-deficient XX genotype was strongly associated with speed performance requiring repeated rapid contractions, but found no association between genotype and strength performance measured through single maximum contractions (Ahn et al., 2015). That’s a meaningful distinction: this gene appears to matter more for explosive, repeated power output than for raw single-effort strength. Separately, research has found that people with the XX genotype tend to experience greater exercise-induced muscle damage and require a longer recovery window after strength training, which could itself affect how quickly visible muscle gains accumulate over time (Del Coso et al., 2022).
An Honest Note on Inconsistency
Not every study agrees on how much this gene matters. One study directly examining muscle power phenotypes in recreationally active adults found no significant relationship between ACTN3 genotype and muscle power at all, concluding the specific phenotypes most influenced by this gene remain uncertain (Clarkson et al., 2010). This gene is one of the most-studied in exercise genetics precisely because its effects, while real, are more nuanced than “have it or don’t.”
MSTN: The Brake Pedal on Muscle Growth
Myostatin, produced by the MSTN gene, actively limits how much skeletal muscle your body builds. Its role was first discovered in cattle and mice, where disabling the gene produced dramatically oversized “double-muscled” animals, and the same biology has since been confirmed directly in humans.
A case report described a child born with a mutation disabling both copies of the MSTN gene, resulting in visibly increased muscle bulk and strength from infancy, providing direct evidence that myostatin regulates muscle mass in humans the same way it does in other mammals (Schuelke et al., 2004). These complete loss-of-function mutations are extremely rare. A far more common variant, K153R, has a much shakier evidence base: a systematic review pooling 71 studies found only a borderline association between the R allele and strength-athlete status, and noted the allele’s frequency varies dramatically by ancestry, from about 3% in Caucasians to 22% in African populations, which complicates drawing firm conclusions (Ismailidis et al., 2022). This is a helpful reminder that a rare, disabling mutation and a common, everyday polymorphism in the same gene can carry very different weights of evidence.
IGF1: Mixed Signals on an Anabolic Growth Pathway
Insulin-like growth factor 1 (IGF-1) is produced in muscle tissue during training and helps activate satellite cells that repair and build new muscle fibers. A repeat-length variant in the IGF1 gene’s promoter region has been studied as a possible influence on this process.
A study of older adults completing a 10-week strength-training program found that carriers of a specific IGF1 promoter variant gained significantly more strength than non-carriers, with a trend toward greater muscle volume as well (Kostek et al., 2005). However, a separate, differently designed study examining a different IGF1 polymorphism in both Black and white older adults found no significant impact on muscle mass response to training in either group (Kostek et al., 2010). Given these mixed results, IGF1 remains a biologically plausible but not yet firmly established piece of the muscle-building puzzle.
What Still Drives Most of the Difference
Progressive overload, adequate protein intake, sleep quality, training consistency, and recovery management remain the dominant factors in muscle growth for the overwhelming majority of people, genetics aside. Even people with a genetic profile associated with slower gains can build substantial muscle with consistent, well-structured training; genetics tends to shift the ceiling and the rate of progress, not whether progress is possible at all.
Where Genetic Testing Fits In
If you’ve wondered why your training results differ from a workout partner’s, a fitness genetic report can walk through markers like these in personalized detail. It’s meant to add context to your training approach, not to predict your results or replace a well-structured program.
Frequently Asked Questions
If I have the ACTN3 XX genotype, should I avoid power-based training?
Not necessarily. This genotype is linked to differences in certain performance measures on average, but many successful athletes carry it, and training approach should be based on your individual response and goals, not genotype alone.
Can I have a “myostatin deficiency” and not know it?
Complete loss-of-function mutations like the one described in case reports are extremely rare. Most people carry fully functional myostatin genes, which is why myostatin-targeting drugs are being developed rather than relying on natural variation.
Does genetic testing tell me exactly how much muscle I can build?
No. These genes explain only a portion of the variation in muscle-building response, and training, nutrition, and consistency remain the largest controllable factors regardless of genetic profile.
